Atossa Therapeutics, Inc. (ATOS) Covered Calls

You can sell covered calls on Atossa Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ATOS (prices last updated Tue 4:16 PM ET):

Atossa Therapeutics, Inc. (ATOS) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.28 0.00 1.27 1.28 471K - 0.2
Covered Calls For Atossa Therapeutics, Inc. (ATOS)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 20 1 0.25 1.03 -2.9% -33.1%
Jan 17 1.5 0.10 1.18 8.5% 51.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Atossa Therapeutics, Inc. develops and markets medical devices, laboratory tests, and therapeutics to address breast health conditions in the United States. The company's lead program is the development of Endoxifen, an active metabolite of tamoxifen which is in Phase II studies to treat and prevent breast cancer. It is also developing intraductal microcatheter technology to target the delivery of therapies, including fulvestrant, immunotherapies, and Chimeric Antigen Receptor T-cell therapies, directly to the site of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2009 and is headquartered in Seattle, Washington.